Dr. Siddhartha Ganguly

Director of the Lymphoma/Myeloma Program
University of Kansas

Siddhartha Ganguly, MD, FACP is Director of the Lymphoma and Myeloma Program at the University of Kansas School of Medicine. He is a member of both the American Society of Hematology and the American Society for Blood and Marrow Transplantation. His research group investigates the role of various treatments, especially stem cell transplantation, in the care of multiple myeloma and other hematological cancers.

Dr. Ganguly completed his residency in internal medicine and fellowship in hematology at the Baylor College of Medicine. He has published numerous articles, lectures and clinical trials, and is a fellow of the American College of Physicians (ACP).

Recurrence

CAR T-Cell Therapy: What It’s Like to Get This Groundbreaking New Cancer Treatment

Recurrence

CAR-T Cell Therapy: A “Revolution” in Cancer Treatment

Recurrence

The Promise — and Perils — of CAR T-Cell Therapy

Recurrence

CAR T Cell Therapy — Where and How to Access the Lifesaving ‘Living Drug’

Living

‘The Eye of the Tiger’ — Why Mindset and Lifestyle are So Important During Treatment for CLL

Cytokine Release Syndrome and CAR T Cell Therapy: Understanding the Risks

Maintenance